Delivery Order SPE2DB22D3301-SPE2DB25FZ1MB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 500 tablets of Topiramate 25 mg at a ceiling value of $8,738.79. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The contract is set for completion by September 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a contract ceiling value of $7,555.16. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The delivery location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order on June 25, 2025, by the Defense Logistics Agency for 500 tablets of Topiramate 25 mg, a generic anticonvulsant and migraine prevention medication commonly used in military and veteran healthcare systems. The delivery order, valued at $19,617.80 with firm fixed pricing, is non-competitive and was issued as a child contract under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of...
- The Defense Logistics Agency has awarded a delivery order valued at $35,132.55 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 5, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a ceiling value of $4,748.01 and an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $5,854.98 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) on May 30, 2025, with completion scheduled for June 2, 2025. This is a firm fixed-price delivery order issued under a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Topiramate 50 mg, a generic anticonvulsant medication commonly used for seizure management and migraine prevention. This firm fixed-price delivery order, valued at $1,005.84, is set to be completed by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $7,564.11 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and was awarded on September 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,281.58 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) with a firm fixed price contract type. This award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation and was competitively awarded. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a $32,008.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg on September 5, 2025, with an ultimate completion date of September 8, 2025. This delivery order was issued without a set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. Topiramate is an anticonvulsant medication commonly...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1MBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of 500 tablets of Topiramate 25 mg, a generic anticonvulsant medication commonly used for seizure management and migraine prevention. Valued at $42,512.13 with a firm fixed price structure, this competitively awarded delivery order is non-set-aside and scheduled for completion by September 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, serving the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a primary pharmaceutical vendor for federal military healthcare systems, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply medications, vaccines, and medical commodities to the Defense Health Agency and other government healthcare entities. The company's role as a critical pharmaceutical distributor positions it to support ongoing medical supply requirements across military and federal health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.5k | 9/24/25 |